Evoke Pharma, Inc. Forecast, price target & analysts
Evoke Pharma, Inc. Target price 2025 - Analyst rating & recommendation
Evoke Pharma, Inc. Classifications & Recommendation:
Evoke Pharma, Inc. Price Target
| Target Price | $18.36 |
| Price | $5.30 |
| Potential |
246.42%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Evoke Pharma, Inc. 2026 .
The average Evoke Pharma, Inc. target price is $18.36.
This is
246.42%
register free of charge
$18.90
256.60%
register free of charge
$18.18
243.02%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Evoke Pharma, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evoke Pharma, Inc. stock has an average upside potential 2026 of
246.42%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.25 | 16.13 |
| 97.88% | 57.38% | |
| Net Margin | -52.20% | -18.47% |
| 65.29% | 64.61% |
3 Analysts have issued a sales forecast Evoke Pharma, Inc. 2025 . The average Evoke Pharma, Inc. sales estimate is
This results in the following potential growth metrics:
3 Evoke Pharma, Inc. Analysts have issued a net profit forecast 2025. The average Evoke Pharma, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.81 | -2.00 |
| 89.95% | 28.83% | |
| P/E | negative | |
| EV/Sales | 0.07 |
3 Analysts have issued a Evoke Pharma, Inc. forecast for earnings per share. The average Evoke Pharma, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Evoke Pharma, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
